메뉴 건너뛰기




Volumn 26, Issue 12, 2013, Pages 1228-1233

Comparison of clinical and laboratory findings in early- and late-onset preeclampsia

Author keywords

Early onset preeclampsia; Late onset preeclampsia; Maternal and perinatal outcomes; Proteinuria

Indexed keywords

BETAMETHASONE; MAGNESIUM SULFATE;

EID: 84880282037     PISSN: 14767058     EISSN: 14764954     Source Type: Journal    
DOI: 10.3109/14767058.2013.776533     Document Type: Article
Times cited : (50)

References (30)
  • 1
    • 80155140296 scopus 로고    scopus 로고
    • A critical review of early-onset and lateonset preeclampsia
    • Raymond D, Peterson E. A critical review of early-onset and lateonset preeclampsia. Obstet Gynecol Surv 2011;66:497-506.
    • (2011) Obstet Gynecol Surv , vol.66 , pp. 497-506
    • Raymond, D.1    Peterson, E.2
  • 3
    • 74549205785 scopus 로고    scopus 로고
    • Different profiles of circulating angiogenic factors and adipocytokines between earlyand late-onset pre-eclampsia
    • Masuyama H, Segawa T, Sumida Y, et al. Different profiles of circulating angiogenic factors and adipocytokines between earlyand late-onset pre-eclampsia. BJOG 2010;117:314-20.
    • (2010) BJOG , vol.117 , pp. 314-320
    • Masuyama, H.1    Segawa, T.2    Sumida, Y.3
  • 4
    • 0033652595 scopus 로고    scopus 로고
    • Risk factors and clinical manifestations of pre-eclampsia
    • Odegard RA, Vatten LJ, Nilsen ST, et al. Risk factors and clinical manifestations of pre-eclampsia. BJOG 2000;107:1410-6.
    • (2000) BJOG , vol.107 , pp. 1410-1416
    • Odegard, R.A.1    Vatten, L.J.2    Nilsen, S.T.3
  • 5
    • 0026059102 scopus 로고
    • Severe pre-eclampsia in the second trimester: Recurrence risk and long-term prognosis
    • Sibai BM, Mercer B, Sarinoglu C. Severe pre-eclampsia in the second trimester: recurrence risk and long-term prognosis. Am J Obstet Gynecol 1991;165:1408-12.
    • (1991) Am J Obstet Gynecol , vol.165 , pp. 1408-1412
    • Sibai, B.M.1    Mercer, B.2    Sarinoglu, C.3
  • 6
    • 79952661789 scopus 로고    scopus 로고
    • Recurrence risk and prediction of a delivery under 34 weeks of gestation after a history of a severe hypertensive disorder
    • Langenveld J, Buttinger A, van der Post J, et al. Recurrence risk and prediction of a delivery under 34 weeks of gestation after a history of a severe hypertensive disorder. BJOG 2011;118:589-95.
    • (2011) BJOG , vol.118 , pp. 589-595
    • Langenveld, J.1    Buttinger, A.2    Van Der Post, J.3
  • 7
    • 77957310407 scopus 로고    scopus 로고
    • Are early and late preeclampsia distinct subclasses of the disease-what does the placenta reveal?
    • vander Merwe JL, Hall DR, Wright C, et al. Are early and late preeclampsia distinct subclasses of the disease-what does the placenta reveal? Hypertens Pregnancy 2010;29:457-67.
    • (2010) Hypertens Pregnancy , vol.29 , pp. 457-467
    • Vander Merwe, J.L.1    Hall, D.R.2    Wright, C.3
  • 8
    • 77649188231 scopus 로고    scopus 로고
    • Clinical differences between earlyonset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum
    • Sep S, Verbeek J, Koek G, et al. Clinical differences between earlyonset HELLP syndrome and early-onset preeclampsia during pregnancy and at least 6 months postpartum. Am J Obstet Gynecol 2010;202:271.e1-5.
    • (2010) Am J Obstet Gynecol , vol.202
    • Sep, S.1    Verbeek, J.2    Koek, G.3
  • 9
    • 85027939012 scopus 로고    scopus 로고
    • The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction
    • Kovo M, Schreiber L, Ben-Haroush A, et al. The placental component in early-onset and late-onset preeclampsia in relation to fetal growth restriction. Prenat Diagn 2012;32:632-7.
    • (2012) Prenat Diagn , vol.32 , pp. 632-637
    • Kovo, M.1    Schreiber, L.2    Ben-Haroush, A.3
  • 10
    • 78149456188 scopus 로고    scopus 로고
    • Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies
    • e13288
    • Rolfo A, Many A, Racano A, et al. Abnormalities in oxygen sensing define early and late onset preeclampsia as distinct pathologies. PLoS One 2010;12(e13288):1-15.
    • (2010) PLoS One , vol.12 , pp. 1-15
    • Rolfo, A.1    Many, A.2    Racano, A.3
  • 11
    • 0035990124 scopus 로고    scopus 로고
    • Mid-trimester triple test levels in early and late onset severe pre-eclampsia
    • Shenhav S, Gemer O, Sassoon E, et al. Mid-trimester triple test levels in early and late onset severe pre-eclampsia. Prenat Diagn 2002;22:579-82.
    • (2002) Prenat Diagn , vol.22 , pp. 579-582
    • Shenhav, S.1    Gemer, O.2    Sassoon, E.3
  • 12
    • 84876519449 scopus 로고    scopus 로고
    • Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery doppler and markers of vasculogenesis during the first trimester of pregnancy
    • Epub ahead of print] doi: 10.1002/uog.12264
    • Parra-Cordero M, Rodrigo R, Barja P, et al. Prediction of early and late pre-eclampsia from maternal characteristics, uterine artery doppler and markers of vasculogenesis during the first trimester of pregnancy. Ultrasound Obstet Gynecol 2012. [Epub ahead of print] doi: 10.1002/uog.12264.
    • (2012) Ultrasound Obstet Gynecol
    • Parra-Cordero, M.1    Rodrigo, R.2    Barja, P.3
  • 13
    • 84861094112 scopus 로고    scopus 로고
    • Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: A systematic review and meta-analysis
    • Kleinrouweler CE, Wiegerinck MM, et al; EBM CONNECT Collaboration. Accuracy of circulating placental growth factor, vascular endothelial growth factor, soluble fms-like tyrosine kinase 1 and soluble endoglin in the prediction of pre-eclampsia: a systematic review and meta-analysis. BJOG 2012;119:778-87.
    • (2012) BJOG , vol.119 , pp. 778-787
    • Kleinrouweler, C.E.1    Wiegerinck, M.M.2
  • 14
    • 0033804534 scopus 로고    scopus 로고
    • Expectant management of early onset, severe pre-eclampsia: Maternal outcome
    • Hall DR, Odendaal HJ, Steyn DW, Grove D. Expectant management of early onset, severe pre-eclampsia: maternal outcome. BJOG 2000;107:1252-7.
    • (2000) BJOG , vol.107 , pp. 1252-1257
    • Hall, D.R.1    Odendaal, H.J.2    Steyn, D.W.3    Grove, D.4
  • 15
    • 73549120198 scopus 로고    scopus 로고
    • Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome
    • Stekkinger E, Zandstra M, Peeters LL, Spaanderman ME. Early-onset preeclampsia and the prevalence of postpartum metabolic syndrome. Obstet Gynecol 2009;114:1076-84.
    • (2009) Obstet Gynecol , vol.114 , pp. 1076-1084
    • Stekkinger, E.1    Zandstra, M.2    Peeters, L.L.3    Spaanderman, M.E.4
  • 16
    • 0036551051 scopus 로고    scopus 로고
    • Diagnosis and management of preeclampsia and eclampsia
    • ACOG Practice Bulletin.Number 33, January 2002. American College of Obstetricians and Gynecologists. ACOG Committee on Obstetric Practice
    • ACOG Practice Bulletin. Diagnosis and management of preeclampsia and eclampsia. Number 33, January 2002. American College of Obstetricians and Gynecologists. ACOG Committee on Obstetric Practice. Int J Gynaecol Obstet 2002;77:67-75.
    • (2002) Int J Gynaecol Obstet , vol.77 , pp. 67-75
  • 18
    • 0035076304 scopus 로고    scopus 로고
    • Pregnancy-related mortality from preeclampsia and eclampsia
    • MacKay AP, Berg CJ, Atrash HK. Pregnancy-related mortality from preeclampsia and eclampsia. Obstet Gynecol 2001;97:533-8.
    • (2001) Obstet Gynecol , vol.97 , pp. 533-538
    • Mackay, A.P.1    Berg, C.J.2    Atrash, H.K.3
  • 20
    • 84862897878 scopus 로고    scopus 로고
    • HELLP Syndrome: 8 years of experience from a tertiary referral center in western Turkey
    • Yildirim G, Gungorduk K, Gul A, et al. HELLP Syndrome: 8 years of experience from a tertiary referral center in western Turkey. Hypertens Pregnancy 2012;31:316-26.
    • (2012) Hypertens Pregnancy , vol.31 , pp. 316-326
    • Yildirim, G.1    Gungorduk, K.2    Gul, A.3
  • 21
    • 0033986126 scopus 로고    scopus 로고
    • Prediction of maternal and fetal complication in preeclampsia
    • Nisell H, Palm K, Wolff K. Prediction of maternal and fetal complication in preeclampsia. Acta Obstet Gynecol Scand 2000;79: 19-23.
    • (2000) Acta Obstet Gynecol Scand , vol.79 , pp. 19-23
    • Nisell, H.1    Palm, K.2    Wolff, K.3
  • 22
    • 40849096217 scopus 로고    scopus 로고
    • Placental origins of preeclampsia: Challenging the current hypothesis
    • Huppertz B. Placental origins of preeclampsia: challenging the current hypothesis. Hypertension 2008;51:970-975.
    • (2008) Hypertension , vol.51 , pp. 970-975
    • Huppertz, B.1
  • 23
    • 70350462557 scopus 로고    scopus 로고
    • Clinical features of fetal growth restriction complicated later by preeclampsia
    • Mitani M, Matsuda Y, Makino Y, et al. Clinical features of fetal growth restriction complicated later by preeclampsia. J Obstet Gynaecol Res 2009;35:882-7.
    • (2009) J Obstet Gynaecol Res , vol.35 , pp. 882-887
    • Mitani, M.1    Matsuda, Y.2    Makino, Y.3
  • 24
    • 33847403913 scopus 로고    scopus 로고
    • Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction?
    • Haddad B, Kayem G, Deis S, Sibai BM. Are perinatal and maternal outcomes different during expectant management of severe preeclampsia in the presence of intrauterine growth restriction? Am J Obstet Gynecol 2007;196:237e1-5.
    • (2007) Am J Obstet Gynecol , vol.196
    • Haddad, B.1    Kayem, G.2    Deis, S.3    Sibai, B.M.4
  • 25
    • 80055086905 scopus 로고    scopus 로고
    • Is fetal growth restriction associated with a more severe maternal phenotype in the setting of early onset pre-eclampsia? A retrospective study
    • e26937
    • Weiler J, Tong S, Palmer KR. Is fetal growth restriction associated with a more severe maternal phenotype in the setting of early onset pre-eclampsia? A retrospective study. PLoS One 2011;6(e26937): 1-5.
    • (2011) PLoS One , vol.6 , pp. 1-5
    • Weiler, J.1    Tong, S.2    Palmer, K.R.3
  • 26
    • 14644414170 scopus 로고    scopus 로고
    • Proteinuria in preeclampsia: How much matters?
    • Chan P, Brown M, Simpson JM, Davis G. Proteinuria in preeclampsia: how much matters? BJOG 2005;112:280-5.
    • (2005) BJOG , vol.112 , pp. 280-285
    • Chan, P.1    Brown, M.2    Simpson, J.M.3    Davis, G.4
  • 27
    • 0037246449 scopus 로고    scopus 로고
    • Perinatal outcomes in pre-eclampsia that is complicated by massive proteinuria
    • Newman M, Robichaux A, Stedman C, et al. Perinatal outcomes in pre-eclampsia that is complicated by massive proteinuria. Am J Obstet Gynecol 2003;188:264-8.
    • (2003) Am J Obstet Gynecol , vol.188 , pp. 264-268
    • Newman, M.1    Robichaux, A.2    Stedman, C.3
  • 28
    • 0036128048 scopus 로고    scopus 로고
    • Urinary protein excretion and expectant management of early onset, severe pre-eclampsia Delivery of patients with early onset, severe preeclampsia
    • Hall DR, Odendaal HJ, Steyn DW, Grove D. Urinary protein excretion and expectant management of early onset, severe pre-eclampsia. Delivery of patients with early onset, severe preeclampsia. Int J Gynaecol Obstet 2002;77:1-6.
    • (2002) Int J Gynaecol Obstet , vol.77 , pp. 1-6
    • Hall, D.R.1    Odendaal, H.J.2    Steyn, D.W.3    Grove, D.4
  • 29
    • 0020520406 scopus 로고
    • Case-control study of severe preeclampsia of early onset
    • Moore MP, Redman CW. Case-control study of severe preeclampsia of early onset. Br Med J 1983;287:580-3.
    • (1983) Br Med J , vol.287 , pp. 580-583
    • Moore, M.P.1    Redman, C.W.2
  • 30
    • 77954279628 scopus 로고    scopus 로고
    • Maternal renal interlobar vein impedance index is higher in early-than in late-onset pre-eclampsia
    • Gyselaers W, Mesens T, Tomsin K, et al. Maternal renal interlobar vein impedance index is higher in early-than in late-onset pre-eclampsia. Ultrasound Obstet Gynecol 2010;36: 69-75.
    • (2010) Ultrasound Obstet Gynecol , vol.36 , pp. 69-75
    • Gyselaers, W.1    Mesens, T.2    Tomsin, K.3


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.